Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3

Z. M. Younossi, M. Stepanova, I. M. Jacobson, T. Asselah, E. J. Gane, E. Lawitz, G. R. Foster, S. K. Roberts, A. J. Thompson, B. E. Willems, T. M. Welzel, B. Pearlman, I. Younossi, A. Racila, L. Henry

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint Dive into the research topics of 'Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3'. Together they form a unique fingerprint.

Medicine & Life Sciences